908 Devices Inc. (MASS)
NASDAQ: MASS · IEX Real-Time Price · USD
6.57
-0.20 (-2.95%)
May 23, 2024, 4:00 PM EDT - Market closed

Company Description

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets.

The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.

Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis.

The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas.

908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

908 Devices Inc.
908 Devices logo
Country United States
Founded 2012
IPO Date Dec 18, 2020
Industry Medical Devices
Sector Healthcare
Employees 230
CEO Dr. Kevin J. Knopp Ph.D.

Contact Details

Address:
645 Summer Street
Boston, Massachusetts 02210
United States
Phone 978-729-4478
Website 908devices.com

Stock Details

Ticker Symbol MASS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $20.00
CIK Code 0001555279
CUSIP Number 65443P102
ISIN Number US65443P1021
Employer ID 45-4524096
SIC Code 3829

Key Executives

Name Position
Dr. Kevin J. Knopp Ph.D. Co-Founder, Chief Executive Officer, President and Director
Dr. Christopher David Brown Ph.D. Co-Founder, Chief Product Officer and Co-Chair of Scientific Advisory Board
Joseph H. Griffith IV Chief Financial Officer and Treasurer
Steve Araiza Co-Founder
Andrew Bartfay Co-Founder and Director of Hardware Development
Michael Jobin Co-Founder and Director of Product Development
Dr. Scott Miller Ph.D. Co-founder and Director of MS Engineering
Michael S. Turner Esq., J.D. Chief Legal and Administrative Officer and Secretary
Don Osmer Vice President of Human Resources

Latest SEC Filings

Date Type Title
May 3, 2024 10-Q Quarterly Report
Apr 30, 2024 8-K Current Report
Apr 30, 2024 8-K Current Report
Apr 29, 2024 ARS Filing
Apr 29, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 29, 2024 DEF 14A Other definitive proxy statements
Mar 8, 2024 S-8 Securities to be offered to employees in employee benefit plans
Mar 8, 2024 10-K Annual Report
Mar 5, 2024 8-K Current Report
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals